EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

NOTCH3 and Pulmonary Arterial Hypertension

Nolan M Winicki iD, Cristian Puerta iD, Casandra E Besse, Yu Zhang, Patricia A Thistlethwaite

International Journal of Molecular Sciences · 06.06.2024 · 25 (11) · 6248

DOI: 10.3390/ijms25116248 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 06.06.2024. Verfasst von Nolan M Winicki und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiothoracic Surgery, University of California, 9300 Campus Point Drive, La Jolla, San Diego, CA 92037-7892, USA. Hauptthemen laut MEDLINE: Receptor, Notch3, Signal Transduction, Pulmonary Arterial Hypertension. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

NOTCH3 receptor signaling has been linked to the regulation of smooth muscle cell proliferation and the maintenance of smooth muscle cells in an undifferentiated state. Pulmonary arterial hypertension (World Health Organization Group 1 idiopathic disease: PAH) is a fatal disease characterized clinically by elevated pulmonary vascular resistance caused by extensive vascular smooth muscle cell proliferation, perivascular inflammation, and asymmetric neointimal hyperplasia in precapillary pulmonary arteries. In this review, a detailed overview of the specific role of NOTCH3 signaling in PAH, including its mechanisms of activation by a select ligand, downstream signaling effectors, and physiologic effects within the pulmonary vascular tree, is provided. Animal models showing the importance of the NOTCH3 pathway in clinical PAH will be discussed. New drugs and biologics that inhibit NOTCH3 signaling and reverse this deadly disease are highlighted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, Notch3Signal TransductionPulmonary Arterial HypertensionHumansAnimalsPulmonary ArteryHypertension, PulmonaryMuscle, Smooth, VascularMyocytes, Smooth Muscle

Stichwörter der Autor:innen

DLL-4HES-5JAG-1NOTCH3Notch3PAHpulmonary arterial hypertension

Substanzen

Receptor, Notch3NOTCH3 protein, human

Autor:innen und Institutionen

  • Division of Cardiothoracic Surgery, University of California, 9300 Campus Point Drive, La Jolla, San Diego, CA 92037-7892, USA.

ORCID-Profile: Nolan M Winicki, Cristian Puerta

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Winicki, N. M., Puerta, C., Besse, C. E., Zhang, Y., & Thistlethwaite, P. A. (2024). NOTCH3 and Pulmonary Arterial Hypertension. International Journal of Molecular Sciences, 25(11), 6248. https://doi.org/10.3390/ijms25116248

Vancouver

Winicki NM, Puerta C, Besse CE, Zhang Y, Thistlethwaite PA. NOTCH3 and Pulmonary Arterial Hypertension. International Journal of Molecular Sciences. 2024;25(11):6248. doi:10.3390/ijms25116248

BibTeX
@article{Winicki2024,
  author = {Winicki, Nolan M and Puerta, Cristian and Besse, Casandra E and Zhang, Yu and Thistlethwaite, Patricia A},
  title = {NOTCH3 and Pulmonary Arterial Hypertension},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {11},
  pages = {6248},
  doi = {10.3390/ijms25116248}
}
Kostenlos starten →